Compare Agilent Technologies Inc (A) vs Vanguard Intermediate Term Corporate Bond ETF (VCIT) Price & Performance
Price performance
Price movement over the last 24 hours
Key statistics
Key statistics
Agilent Technologies Inc vs Vanguard Intermediate Term Corporate Bond ETF — how do they compare? Agilent Technologies Inc trades at $128.27 (market cap $37.04B), while Vanguard Intermediate Term Corporate Bond ETF trades at $81.72. The key difference: Agilent Technologies Inc pays a 0.78% dividend while Vanguard Intermediate Term Corporate Bond ETF pays none, and Agilent Technologies Inc is trading nearer its 52-week high, Vanguard Intermediate Term Corporate Bond ETF nearer its low. Which is the better fit depends on your goals.
| A | VCIT | |
|---|---|---|
Market Cap | $37.04B | — |
Sector | Health | Fixed Income |
52-Week High | $157.20 | $84.82 |
52-Week Low | $110.24 | $81.54 |
Enterprise Value | $38.59B | — |
Dividend Yield | 0.78% | — |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Agilent Technologies (A) trades at $131.14, up 0.34% on the day, with a bearish technical signal but strong analyst support. The stock shows solid profitability with a net margin of 19.55% and ROE of 21.33%, supported by recent earnings beats. Recent acquisitions like Biocare Medical highlight growth initiatives, while cash flow trends remain positive. Valuation ratios such as P/E of 26.22 are elevated but align with quality growth expectations.
The outlook is positive given analyst consensus with a $154.90 price target and 77.5% buy ratings. Risks include execution of acquisitions and macroeconomic pressures on life sciences spending. The stock offers growth potential from AI-driven product launches, though technical resistance near $132 may cap near-term gains.
VCIT trades at $82.39 with minimal daily movement (+0.06%) amid bearish technical signals from moving averages. The ETF maintains a competitive 0.03% expense ratio and approximately 5.17% SEC yield, positioning it as a cost-effective intermediate-term corporate bond option. Recent dividend distributions of $0.33-$0.34 highlight consistent income generation, though technical indicators show 14 sell signals against 2 buy signals.
Outlook remains cautious due to bearish technical momentum and corporate bond market sensitivity to interest rate changes. The fund's low-cost structure and steady yield appeal to income-focused investors, but potential volatility from Federal Reserve policy shifts presents near-term risk. Current levels near support at $82 require monitoring for breakdown confirmation.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
About Agilent Technologies Inc
Originally spun out of Hewlett-Packard in 1999, Agilent has evolved into a leading life sciences and diagnostics firm. Today, Agilent's measurement technologies serve a broad base of customers with its three operating segments: life science and applied tools (45% of fiscal 2021 sales), cross lab (35% of sales consisting of consumables and services related to its life science and applied tools), and diagnostics and genomics (20%). Over half of its sales are generated from the biopharmaceutical, chemical, and energy end markets, but it also supports clinical lab, environmental, forensics, food, academic, and government-related organizations. The company is geographically diverse, with operations in the U.S. (34%) and China (20%) representing the largest country concentrations.
Read more on A →About Vanguard Intermediate Term Corporate Bond ETF
VCIT tracks the Bloomberg U.S. 5-10 Year Corporate Bond Index, providing exposure to investment-grade debt from industrial, utility, and financial companies. It acts as a middle-ground bond fund, offering higher yields than short-term bonds with less price volatility than long-term corporate debt.
Read more on VCIT →
